Biosion is a biotech company focusing on the discovery and preclinical development of innovative biologicals for unmet medical needs. Leveraging its proprietary H³ (High-throughput High-content High-efficiency) antibody platform and SynAb™ technology, Biosion is committed to develop antibody drug candidates with optimal specificity and mechanistic drug properties.
The discovery and early development...